• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Oligodendroglioma Global Clinical Trials Review, H1, 2012 - Product Image

Oligodendroglioma Global Clinical Trials Review, H1, 2012

  • ID: 2051200
  • January 2012
  • Region: Global
  • 91 pages
  • GlobalData

Oligodendroglioma Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, “Oligodendroglioma Global Clinical Trials Review, H1, 2012" provides data on the Oligodendroglioma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Oligodendroglioma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Oligodendroglioma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific READ MORE >



List of Tables
List of Figures
Introduction
Oligodendroglioma
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Oligodendroglioma
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Oligodendroglioma Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Tocagen Inc.
Clinical Trial Overview of Tocagen Inc.
TransMolecular, Inc.
Clinical Trial Overview of TransMolecular, Inc.
AOI Pharmaceuticals, Incorporated
Clinical Trial Overview of AOI Pharmaceuticals, Incorporated
INSYS Therapeutics, Inc.
Clinical Trial Overview of INSYS Therapeutics, Inc.
Teva Pharmaceuticals USA, Inc.
Clinical Trial Overview of Teva Pharmaceuticals USA, Inc.
Pharmacyclics, Inc.
Clinical Trial Overview of Pharmacyclics, Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
City of Hope National Medical Center
Clinical Trial Overview of City of Hope National Medical Center
Case Comprehensive Cancer Center
Clinical Trial Overview of Case Comprehensive Cancer Center
Dana-Farber Cancer Institute
Clinical Trial Overview of Dana-Farber Cancer Institute
Wake Forest University
Clinical Trial Overview of Wake Forest University
University of California, San Francisco
Clinical Trial Overview of University of California, San Francisco
University of Pittsburgh
Clinical Trial Overview of University of Pittsburgh
Ohio State University Comprehensive Cancer Center
Clinical Trial Overview of Ohio State University Comprehensive Cancer Center
Les Hopitaux Universitaires de Strasbourg
Clinical Trial Overview of Les Hopitaux Universitaires de Strasbourg
European Organization for Research and Treatment of Cancer
Clinical Trial Overview of European Organization for Research and Treatment of Cancer
Abramson Cancer Center
Clinical Trial Overview of Abramson Cancer Center
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
Ludwig-Maximilians-Universitat Munich
Clinical Trial Overview of Ludwig-Maximilians-Universitat Munich
Northwestern University
Clinical Trial Overview of Northwestern University
University of California, Los Angeles
Clinical Trial Overview of University of California, Los Angeles
Sun Yat-sen University
Clinical Trial Overview of Sun Yat-sen University
Radiation Therapy Oncology Group
Clinical Trial Overview of Radiation Therapy Oncology Group
Roswell Park Cancer Institute
Clinical Trial Overview of Roswell Park Cancer Institute
Weill Cornell Medical College
Clinical Trial Overview of Weill Cornell Medical College
Hopitaux Universitaires de Geneve
Clinical Trial Overview of Hopitaux Universitaires de Geneve
H. Lee Moffitt Cancer Center & Research Institute
Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

List of Tables
Oligodendroglioma Therapeutics Market, Global, Clinical Trials by Zone, 2012-
Oligodendroglioma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Oligodendroglioma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Oligodendroglioma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012-
Oligodendroglioma Therapeutics Clinical Trials, Europe, Top Five Countries, 2012-
Oligodendroglioma Therapeutics Clinical Trials, North America, Top Countries, 2012-
Oligodendroglioma Therapeutics Clinical Trials, BRIC Countries, 2012-
Oligodendroglioma Therapeutics Clinical Trials, G7 Countries, 2012-
Oligodendroglioma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Oligodendroglioma Therapeutics Clinical Trials, E7 Countries, 2012-
Oligodendroglioma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Oligodendroglioma Therapeutics Market, Global, Clinical Trials by Phase, 2012-
Oligodendroglioma Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012-
Oligodendroglioma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Oligodendroglioma Therapeutics Market, Global, Withdrawn Clinical Trials, 2012-
Oligodendroglioma Therapeutics Market, Global, Terminated Clinical Trials, 2012-
Oligodendroglioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Oligodendroglioma Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Oligodendroglioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Oligodendroglioma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Tocagen Inc., 2012-
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by TransMolecular, Inc., 2012-
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by AOI Pharmaceuticals, Incorporated, 2012-
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by INSYS Therapeutics, Inc., 2012-
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceuticals USA, Inc., 2012-
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmacyclics, Inc., 2012-
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2012-
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012-
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012-
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2012-
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012-
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012-
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohio State University Comprehensive Cancer Center, 2012-
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Les Hopitaux Universitaires de Strasbourg, 2012-
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2012-
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Abramson Cancer Center, 2012-
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012-
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Ludwig-Maximilians-Universitat Munich, 2012-
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012-
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2012-
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2012-
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2012-
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012-
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2012-
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Hopitaux Universitaires de Geneve, 2012-
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center & Research Institute, 2012-

List of Figures
Oligodendroglioma Therapeutics Market, Global, Clinical Trials by Zone (%), 2012-
Oligodendroglioma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Oligodendroglioma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Oligodendroglioma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012-
Oligodendroglioma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012-
Oligodendroglioma Therapeutics Clinical Trials, G7 Countries (%), 2012-
Oligodendroglioma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Oligodendroglioma Therapeutics Clinical Trials, E7 Countries (%), 2012-
Oligodendroglioma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Oligodendroglioma Therapeutics Market, Global, Clinical Trials by Phase (%), 2012-
Oligodendroglioma Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012-
Oligodendroglioma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Oligodendroglioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Oligodendroglioma Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Oligodendroglioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Oligodendroglioma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
GlobalData Methodology

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos